65,437 trials
Pain With Paracervical Block · Pain With Gynecology Procedure · Pain
Primary: Pain With Paracervical Block — 27; 20 units on a scale
Suicide
Primary: Proportion of Patients in the Target Population Who Agree to Participate — 0.384 proportion of potential participants
Dementia · Quality of Life · Caregiver Stress
Primary: Feasibility for the Caregiver to Engage With and Complete Baseline Assessments. — 50 Participants
Moderate to Severe Opioid-use Disorder
Primary: Maintenance Phase: Percentage of Responders for Weekly Opioid Use Over Weeks 20 to 38 — 44; 50 Participants — p=0.4819
Non-Alcoholic Fatty Liver Disease · Obesity
Primary: Change in Hepatic Steatosis — -2.25; -1.3; -5.48; -0.17 liver fat percentage
Campylobacter Infections
Primary: Number of Participants With Solicited or Unsolicited Adverse Events — 15; 16; 17; 16 Participants
Gastric Cancer
Primary: Overall Response Rate (ORR) in Subjects Treated With FLX475 in Combination With Pembrolizumab — 0; 60.0 percentage of participants
Reversible Pulpitis · Ibuprofen
Primary: Change in Pain Intensity From Baseline (Pre-Operative) to Immediately During the Procedure (Day 0), Measured by the Visual Analogue Scale (VAS) — 5.05; 0.64 score on a…
COPD, Chronic Obstructive Pulmonary Disease
Primary: Change in Quality of Life -St. George's Respiratory Questionnaire (SGRQ) — -2.9; 1.5 score on a scale — p=0.025
Cocaine-Related Disorders
Primary: Change in Orbitofrontal Cortex (OFC) BOLD Signal During Cocaine Cue Reactivity Task (Pre- vs. Post-TBS) — -0.0026; 0.0007 BOLD signal
Healthy
Primary: Maximum Voluntary Isometric Contraction (N) — 54.8; 65.8; 52.2; 33.8 Newton
Accidental Fall
Primary: Trunk Angle at Touchdown of the First Recovery Step — 27.0; 24.6; 28.4 degrees
Cancer
Primary: PRO Adherence — 50.0; 56.9; 34.9 pct. assigned questionnaires completed
Plaque Psoriasis
Primary: Absolute Treatment Satisfaction Questionnaire for Medication Version 9 (TSQM-9) Domain Total Score at Week 12 — 73.56; 72.07; 75.97 Score on a scale
Metabolic Syndrome · Metabolic Endotoxemia
Primary: Serum Endotoxin — 32.5; 30.6 EU/ml